COMMUNIQUÉS West-GlobeNewswire

Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
25/06/2019
SOUTH SAN FRANCISCO, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25/06/2019
SOUTH SAN FRANCISCO, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit
25/06/2019
SAN FRANCISCO, June 25, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Paratek Pharmaceuticals Promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman
25/06/2019
Adam Woodrow Promoted to President & Retains Chief Commercial Officer Position Randy Brenner Promoted to Chief Development & Regulatory Officer BOSTON, June 25, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, [...]
Cannabis Suisse Corp., a Research & Development Company Licensed Under Swiss Cannabis, is Pleased to Announce the Installation of the Art Surveillance Equipment to Enable an Around the Clock Webcast of Our Facilities in Switzerland
25/06/2019
Dietikon, Switzerland, June 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Suisse Corp. is pleased to announce we have installed state of the art surveillance equipment to enable an around the clock webcast [...]
Major Shareholder Announcement
25/06/2019
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; June 25, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 30 of the Danish Capital Markets Act that [...]
Women’s Hormone Network Launches November Symposium for Medical Practitioners: 21st Century Hormone Advancements
25/06/2019
The Practitioner’s Comprehensive Guide to Bioidentical Hormones through Menopause and Andropause IRVINE, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- The Women’s Hormone Network announced its upcoming educational hormone [...]
Artelo Biosciences Announces Closing of $8.0 Million Public Offering and Partial Exercise and Closing of Over-Allotment Option
25/06/2019
LA JOLLA, Calif., June 25, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NasdaqCM: ARTL, ARTLW) (the “Company” or “Artelo Biosciences”), a clinical-stage biopharmaceutical company with a portfolio of novel [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
25/06/2019
Company Announcement Copenhagen, Denmark; June 25, 2019 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 9,577 shares as a consequence of the exercise of employee warrants. The increase is [...]
North Bud Farms Signs Binding Letter of Intent to Acquire Nevada Botanical Science
25/06/2019
TORONTO, June 25, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") is pleased to announce that it has entered into a binding letter of intent (“LOI”), effective June [...]
New healthcare price comparison tool supports President Trump claims about transparency
25/06/2019
HOUSTON, June 25, 2019 (GLOBE NEWSWIRE) -- How much would a patient rather pay for an MRI—$90 or $4,500? That is the range that healthcare providers charge for an MRI of the arm joint in Houston, Texas according to [...]
Nymox End of Q2 New Investor Presentation on Website
25/06/2019
HASBROUCK HEIGHTS, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to provide an up-to-date investor communication presentation posted on the Nymox website today as the [...]
Lumere Upgrades Product Introduction Management Platform with Spend Analytics
25/06/2019
Platform surpasses 30,000 medical devices analyzed in Q1 2019 CHICAGO, June 25, 2019 (GLOBE NEWSWIRE) -- Lumere , Inc., a leading provider of evidence-based analytics and services to reduce costly and unwarranted [...]
PracticeSuite Set to Offer Physicians End-to-End Chronic Care Management
25/06/2019
PracticeSuite doctors will now be able to effortlessly participate in CMS’s Chronic Care Management program and offer higher levels of service to patients that need it SILICON VALLEY, Calif., June 25, 2019 (GLOBE [...]
Lixte Biotechnology’s PP2A Inhibitor, LB-100, Improves Brain Function and Motor Impairment in a Mouse Model of Angelman Syndrome, a Rare Human Neurodevelopmental Disorder
25/06/2019
EAST SETAUKET, NY, June 25, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. ( OTCQB: LIXT ) noted that a group of neuroscientists in China and Japan reported that Lixte’s lead clinical compound, LB-100, [...]
Precipio and H3 Biomedicine Sign Second Development Agreement
25/06/2019
Companies to create a panel amplifying targeted regions of key cancer genes NEW HAVEN, Conn., June 25, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced the initiation of [...]
Relievant Announces Publication of Level I INTRACEPT Study
25/06/2019
Intracept® Procedure Demonstrates Highly Significant Treatment Effect vs. Standard Care MINNEAPOLIS, June 25, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company focused on [...]
Comfort Keepers® declares June 26 National Day of Joy, releases State of Joy survey results
25/06/2019
Survey finds seniors are the nation’s most joyful demographic IRVINE, California, June 25, 2019 (GLOBE NEWSWIRE) -- To raise awareness about the need for more joy in the world, and to encourage people to spread joy to [...]
AXIM® Biotechnologies Signs Supply Agreement to Register Cannabinoid Oral Care Products in Clinical Trials for Gingivitis and Gum Disease
25/06/2019
Leading Cannabinoid Biotech Company Announces Use of Oral Care Product Line in Registration for Clinical Trials in Australia and New Zealand NEW YORK, June 25, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc . (OTC [...]

Pages